
|Articles|October 1, 2009
- Applied Clinical Trials-10-01-2009
- Volume 0
- Issue 0
Applied Clinical Trials Digital Edition - October 2009
CRO/SPONSOR : The Value of Late-Phase Patient Reported Outcomes Financial Simulation Modeling in Clinical Trials TRIAL DESIGN : A Concise Look at Adaptive LABS : Steps to Optimize Imaging Also in this issue : New FDA Leadership Means Business, EU Works Together to Improve Trial Rules, Interoperability: A Reality or Just a Dream?, Social Media and Health Care
Advertisement
Articles in this issue
over 16 years ago
Globalization Gets An A+over 16 years ago
Obesity, Lipids, and Diabetesover 16 years ago
Late Phase Patient Reported Outcomesover 16 years ago
FDA Promotes Integrity and Complianceover 16 years ago
Pressure Mounts for ICH GCP Revisionsover 16 years ago
Business and People Update October 2009over 16 years ago
The Semantics of Health Care Interoperabilityover 16 years ago
Operation Adaptiveover 16 years ago
Financial Simulation Modelingover 16 years ago
Working Toward a Better FutureNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
2
Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations
3
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
4
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
5




